Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Risk Neuroblastoma Study 1 (SIOPEN)
NCT00030719Phase 3Unknown
- Sponsor
- University of Leicester
- Start
- Dec 2001
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 13
01
Overview
A Phase 3 trial of Dinutuximab beta in neuroblastoma, sponsored by University of Leicester. Status: unknown.
02
Drugs
Dinutuximab beta
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT00030719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00030719.